🇺🇸 FDA
Patent

US 9611258

Dual MEK/PI3K inhibitors and therapeutic methods using the same

granted A61PA61P35/00

Quick answer

US patent 9611258 (Dual MEK/PI3K inhibitors and therapeutic methods using the same) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P35/00